RXST•benzinga•April 3, 2025 at 06:32 AM

Reported Earlier, RxSight Preliminary Q1 Results: Expects Revenue of $37.9M, Up 28% YoY (Vs. $40.14M Est.); Lowers 2025 Revenue Guidance To $160M–$175M (Vs. $188.9M Est.), Down From $185M–$197M

No summary available.

Read the full article from the original source for complete details and context.

Article published on April 3, 2025 by benzinga